TP53 and viral infectious disease: Similar reports of disruption in the DNA-binding domain of p53 to augment viral infection in the host have been remarked in the case of Epstein–Barr virus (EBV) and high-risk HPV infections (Sato et al., 2009; Martinez-Zapien et al., 2016).